glp 1 drugs origin The GLP-1 revolution: What UAB researchers are discovering about how these work GIPR/GLP-1R dual agonist therapies for
Description
Shaman AM, Bain SC, Bakris GL, Buse JB, Idorn T, Mahaffey KW, et al
GLP-1 patient trends: demographics and adherence patterns Usage across the population A nationally representative survey conducted by RAND found that 11.8% of Americans have used GLP-1 drugs for weight loss, and about 14% express interest, while 74% say they do not plan to take them
This dual benefit makes them an important option for tackling multiple health issues
Mortenson, D
Access this article Similar content being viewed by others References Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, et al
